Otto Schwarz, PhD, is the former COO of Actelion Pharmaceuticals Ltd (2008-2017). He is a pharmacist with a PhD from the University of Vienna and was a post-doc at the University of Florida. Currently, he is Managing Director of Concentus Consulting, Switzerland. Prior to Actelion, he was Executive Board Member of Altana Pharma, Germany (2004-2008) and before that spent 16 years at Schering-Plough and 4 years at Eli Lilly. He is currently on the board of privately held Stalicla, Lausanne, and has been a board member of Kiadis Pharma AB/Netherlands and Chairman of the Board of Arvelle Therapeutics/Netherlands until the sale of both companies in 2021. He also served for 3 years as member of the foundation board of the MAX7 Foundation/Germany.

At Santhera, Otto Schwarz, PhD, serves as Board member since the AGM 2023.